HBV Mutation Detail Information

> S202G Search Result


Mutation Information
Mutation Site S202G
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.L180M+rt.M204I+rt.S202G;rt.L180M+rt.M204I+rt.M204V+rt.S202G;rt.L180M+rt.M204V+rt.S202G+rt.T184L;rt.L180M+rt.M204V+rt.S202G+rt.T184L+rt.T184A;rt.L180M+rt.M204V+rt.S202G+rt.T184I;rt.M204V+rt.S202G+rt.T184I;rt.L180M+rt.M204V+rt.M250I+rt.S202G;rt.L180M+rt.M204V+rt.M250L+rt.S202G;rt.L180M+rt.M204V+rt.S202G+rt.T184A;rt.M204V+rt.S202G+rt.L180M;rt.M204V+rt.S202G+rt.A181C+rt.L180M
Genotype/Subtype C
Relevant Drug entecavir (ETV);lamivudine (LAM);adefovir dipivoxil (ADV);tenofovir (TDF)
Country China
Literature Information
PubMed PMID 30866789
Disease HBV infection
Published Year 2019
Journal Emerging microbes & infections
Title Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice.
Author Liu Y,Zhou Y,Li X,Niu M,Chen R,Shao J,Si L,Luo D,Lin Y,Li L,Zhang K,Xiao X,Xu Z,Liu M,Lu M,Zoulim F,Xu D
Evidence Patient-derived representative rtA181C-containing mutants, rtL180M+A181C+M204V, rtL180M+A181C+M204V+M250V, and rtL180M+A181C+S202G+M204V, exhibited 45.7%, 25.9%, and 25.0% replication capacity and 85.6-, 356.1-, and 307.1-fold decreased susceptibility to ETV respectively compared to the wild-type strain, while the three mutants remained sensitive to tenofovir (TDF).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation